文献速递冠心病

COVID-19大流行期间急性心肌梗死的病例率、治疗方式与结局

Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic.
PubMed 文献 · JAMA Cardiol · 2020-01-01

从2020年2月23日起,AMI住院率每周下降19.0例,持续5周,随后每周增加10.5例。早期COVID-19期间AMI的O/E死亡比值升高至1.27,STEMI患者尤为显著(1.96),后期STEMI的O/E比值进一步升至2.40。

要点

  • COVID-19早期AMI住院率每周下降19.0例,后期每周回升10.5例。
  • 早期COVID-19期间AMI的O/E死亡比值升至1.27,STEMI患者达1.96。
  • 后期STEMI的O/E死亡比值进一步升至2.40,风险调整后OR为1.52。

核心结论

  • COVID-19早期和后期AMI住院率发生显著变化,且结局更差,STEMI患者死亡风险增加尤为突出。

主要发现

  • 从2020年2月23日起,AMI住院病例每周减少19.0例(95%CI -29.0至-9.0),持续5周;此后每周增加10.5例(95%CI +4.6至+16.5)。
  • 各时期患者人口学特征、心血管合并症和治疗方式无显著差异。
  • 早期COVID-19期间AMI的O/E死亡比值为1.27(95%CI 1.07-1.48),STEMI患者为1.96(95%CI 1.22-2.70)。
  • 后期COVID-19期间AMI的O/E死亡比值无统计学差异(1.23,95%CI 0.98-1.47),但STEMI患者为2.40(95%CI 1.65-3.16),风险调整后OR为1.52(95%CI 1.02-2.26)。

临床怎么用

  • 疫情期间需关注AMI住院率下降及STEMI患者死亡风险升高,优化急救流程与资源配置。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The coronavirus disease 2019 (COVID-19) pandemic has changed health care delivery worldwide. Although decreases in hospitalization for acute myocardial infarction (AMI) have been reported during the pandemic, the implication for in-hospital outcomes is not well understood. OBJECTIVE: To define changes in AMI case rates, patient demographics, cardiovascular comorbidities, treatment approaches, and in-hospital outcomes during the pandemic. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study retrospectively analyzed AMI hospitalizations that occurred between December 30, 2018, and May 16, 2020, in 1 of the 49 hospitals in the Providence St Joseph Health system located in 6 states (Alaska, Washington, Montana, Oregon, California, and Texas). The cohort included patients aged 18 years or older who had a principal discharge diagnosis of AMI (ST-segment elevation myocardial infarction [STEMI] or non-ST-segment elevation myocardial infarction [NSTEMI]). Segmented regression analysis was performed to assess changes in weekly case volumes. Cases were grouped into 1 of 3 periods: before COVID-19 (December 30, 2018, to February 22, 2020), early COVID-19 (February 23, 2020, to March 28, 2020), and later COVID-19 (March 29, 2020, to May 16, 2020). In-hospital mortality was risk-adjusted using an observed to expected (O/E) ratio and covariate-adjusted multivariable model. EXPOSURE: Date of hospitalization. MAIN OUTCOMES AND MEASURES: The primary outcome was the weekly rate of AMI (STEMI or NSTEMI) hospitalizations. The secondary outcomes were patient characteristics, treatment approaches, and in-hospital outcomes of this patient population. RESULTS: The cohort included 15 244 AMI hospitalizations (of which 4955 were for STEMI [33%] and 10 289 for NSTEMI [67%]) involving 14 724 patients (mean [SD] age of 68 [13] years and 10 019 men [66%]). Beginning February 23, 2020, AMI-associated hospitalizations decreased at a rate of -19.0 (95% CI, -29.0 to -9.0) cases per week for 5 weeks (early COVID-19 period). Thereafter, AMI-associated hospitalizations increased at a rate of +10.5 (95% CI, +4.6 to +16.5) cases per week (later COVID-19 period). No appreciable differences in patient demographics, cardiovascular comorbidities, and treatment approaches were observed across periods. The O/E mortality ratio for AMI increased during the early period (1.27; 95% CI, 1.07-1.48), which was disproportionately associated with patients with STEMI (1.96; 95% CI, 1.22-2.70). Although the O/E mortality ratio for AMI was not statistically different during the later period (1.23; 95% CI, 0.98-1.47), increases in the O/E mortality ratio were noted for patients with STEMI (2.40; 95% CI, 1.65-3.16) and after risk adjustment (odds ratio, 1.52; 95% CI, 1.02-2.26). CONCLUSIONS AND RELEVANCE: This cross-sectional study found important changes in AMI hospitalization rates and worse outcomes during the early and later COVID-19 periods. Future studies are needed to identify contributors to the increased mortality rate among patients with STEMI.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Gluckman TJ, Wilson MA, Chiu ST, et al. Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic. JAMA Cardiol. 2020. PMID: 32766756. doi:10.1001/jamacardio.2020.3629

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。